These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 28347847

  • 1. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
    Mönckedieck M, Kamplade J, Fakner P, Urbanetz NA, Walzel P, Steckel H, Scherließ R.
    Int J Pharm; 2017 May 30; 524(1-2):351-363. PubMed ID: 28347847
    [Abstract] [Full Text] [Related]

  • 2. Spray dried mannitol carrier particles with tailored surface properties--the influence of carrier surface roughness and shape.
    Littringer EM, Mescher A, Schroettner H, Achelis L, Walzel P, Urbanetz NA.
    Eur J Pharm Biopharm; 2012 Sep 30; 82(1):194-204. PubMed ID: 22595133
    [Abstract] [Full Text] [Related]

  • 3. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol.
    Kaialy W, Nokhodchi A.
    Eur J Pharm Sci; 2015 Feb 20; 68():56-67. PubMed ID: 25497318
    [Abstract] [Full Text] [Related]

  • 4. Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.
    Kaialy W, Nokhodchi A.
    Pharm Res; 2013 Feb 20; 30(2):458-77. PubMed ID: 23070603
    [Abstract] [Full Text] [Related]

  • 5. Tribo-Charging Behaviour of Inhalable Mannitol Blends with Salbutamol Sulphate.
    Zellnitz S, Pinto JT, Brunsteiner M, Schroettner H, Khinast J, Paudel A.
    Pharm Res; 2019 Apr 09; 36(6):80. PubMed ID: 30968221
    [Abstract] [Full Text] [Related]

  • 6. Performance tuning of particle engineered mannitol in dry powder inhalation formulations.
    Hertel N, Birk G, Scherließ R.
    Int J Pharm; 2020 Aug 30; 586():119592. PubMed ID: 32622814
    [Abstract] [Full Text] [Related]

  • 7. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose.
    Pinto JT, Zellnitz S, Guidi T, Roblegg E, Paudel A.
    Mol Pharm; 2018 Jul 02; 15(7):2827-2839. PubMed ID: 29856921
    [Abstract] [Full Text] [Related]

  • 8. Effect of carrier particle shape on dry powder inhaler performance.
    Kaialy W, Alhalaweh A, Velaga SP, Nokhodchi A.
    Int J Pharm; 2011 Dec 12; 421(1):12-23. PubMed ID: 21945739
    [Abstract] [Full Text] [Related]

  • 9. Particle engineered mannitol for carrier-based inhalation - A serious alternative?
    Hertel N, Birk G, Scherließ R.
    Int J Pharm; 2020 Mar 15; 577():118901. PubMed ID: 31846726
    [Abstract] [Full Text] [Related]

  • 10. Carrier-based dry powder inhalation: Impact of carrier modification on capsule filling processability and in vitro aerodynamic performance.
    Faulhammer E, Wahl V, Zellnitz S, Khinast JG, Paudel A.
    Int J Pharm; 2015 Aug 01; 491(1-2):231-42. PubMed ID: 26136200
    [Abstract] [Full Text] [Related]

  • 11. Performance indicators for carrier-based DPIs: Carrier surface properties for capsule filling and API properties for in vitro aerosolisation.
    Faulhammer E, Zellnitz S, Wutscher T, Stranzinger S, Zimmer A, Paudel A.
    Int J Pharm; 2018 Jan 30; 536(1):326-335. PubMed ID: 29217472
    [Abstract] [Full Text] [Related]

  • 12. Elucidation of lactose fine size and drug shape on rheological properties and aerodynamic behavior of dry powders for inhalation.
    Sun Y, Yu D, Li J, Zhao J, Feng Y, Zhang X, Mao S.
    Eur J Pharm Biopharm; 2022 Oct 30; 179():47-57. PubMed ID: 36029939
    [Abstract] [Full Text] [Related]

  • 13. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO, Molokhia AM, Elsayed MM.
    Eur J Pharm Biopharm; 2015 Oct 30; 96():291-303. PubMed ID: 26275831
    [Abstract] [Full Text] [Related]

  • 14. Influence of carrier on the performance of dry powder inhalers.
    Saint-Lorant G, Leterme P, Gayot A, Flament MP.
    Int J Pharm; 2007 Apr 04; 334(1-2):85-91. PubMed ID: 17113733
    [Abstract] [Full Text] [Related]

  • 15. Influence of carrier surface fines on dry powder inhalation formulations.
    Boshhiha AM, Urbanetz NA.
    Drug Dev Ind Pharm; 2009 Aug 04; 35(8):904-16. PubMed ID: 19466888
    [Abstract] [Full Text] [Related]

  • 16. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
    Kaialy W, Martin GP, Ticehurst MD, Momin MN, Nokhodchi A.
    Int J Pharm; 2010 Jun 15; 392(1-2):178-88. PubMed ID: 20363301
    [Abstract] [Full Text] [Related]

  • 17. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.
    Li X, Vogt FG, Hayes D, Mansour HM.
    J Aerosol Med Pulm Drug Deliv; 2014 Apr 15; 27(2):81-93. PubMed ID: 24502451
    [Abstract] [Full Text] [Related]

  • 18. Towards a more desirable dry powder inhaler formulation: large spray-dried mannitol microspheres outperform small microspheres.
    Kaialy W, Hussain T, Alhalaweh A, Nokhodchi A.
    Pharm Res; 2014 Jan 15; 31(1):60-76. PubMed ID: 23918220
    [Abstract] [Full Text] [Related]

  • 19. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X, Vogt FG, Hayes D, Mansour HM.
    J Pharm Sci; 2014 Sep 15; 103(9):2937-2949. PubMed ID: 24740732
    [Abstract] [Full Text] [Related]

  • 20. Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler.
    Ferdynand MS, Nokhodchi A.
    Drug Deliv Transl Res; 2020 Oct 15; 10(5):1418-1427. PubMed ID: 31933129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.